Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022

SELL
$43.12 - $50.3 $29,321 - $34,204
-680 Reduced 61.82%
420 $18,000
Q4 2021

Jan 18, 2022

BUY
$47.6 - $65.0 $4,760 - $6,500
100 Added 10.0%
1,100 $55,000
Q4 2020

Jan 21, 2021

SELL
$54.4 - $73.42 $5,440 - $7,342
-100 Reduced 9.09%
1,000 $73,000
Q2 2020

Jul 22, 2020

SELL
$61.66 - $70.16 $12,332 - $14,032
-200 Reduced 15.38%
1,100 $73,000
Q4 2019

Feb 06, 2020

BUY
$74.18 - $97.92 $96,434 - $127,296
1,300 New
1,300 $114,000
Q1 2019

May 10, 2019

SELL
$85.97 - $108.09 $8,597 - $10,809
-100 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$78.25 - $107.92 $19,640 - $27,087
-251 Reduced 71.51%
100 $8,000
Q2 2018

Aug 10, 2018

SELL
$97.62 - $120.59 $53,593 - $66,203
-549 Reduced 61.0%
351 $40,000
Q4 2017

Jan 17, 2018

BUY
$104.5 - $126.38 $83,600 - $101,104
800 Added 800.0%
900 $94,000
Q3 2017

Oct 17, 2017

BUY
$97.26 - $116.2 $9,726 - $11,620
100
100 $11,000

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.